Penam Laboratories Profile
Key Indicators
- Authorised Capital ₹ 11.00 Cr
as on 15-06-2024
- Paid Up Capital ₹ 5.17 Cr
as on 15-06-2024
- Company Age 35 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 61.95 Cr
as on 15-06-2024
- Revenue 47.57%
(FY 2023)
- Profit 36.58%
(FY 2023)
- Ebitda 64.00%
(FY 2023)
- Net Worth 12.32%
(FY 2023)
- Total Assets 19.60%
(FY 2023)
About Penam Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 11.00 Cr and a paid-up capital of Rs 5.17 Cr.
The company has closed loans amounting to ₹61.95 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Raj Ajmani, Surender Ajmani, Paras Pandey, and Five other members serve as directors at the Company.
- CIN/LLPIN
U24231DL1989PLC037287
- Company No.
037287
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
07 Aug 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Penam Laboratories Limited offer?
Penam Laboratories Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API.
Who are the key members and board of directors at Penam Laboratories?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Surender Ajmani  | Managing Director | 07-Aug-1989 | Current |
| Paras Pandey | Managing Director | 07-Aug-1989 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vikas Pandey | Whole-Time Director | 30-Sep-2020 | Current |
| Raj Ajmani | Director | 29-Sep-2018 | Current |
| Ashish Ajmani | Whole-Time Director | 05-Oct-2009 | Current |
| Arun Mittal | Director | 20-Mar-1993 | Current |
| Narinder Jhanji | Director | 05-Oct-2009 | Current |
| Abha Pandey | Director | 29-Sep-2018 | Current |
Financial Performance and Corporate Structure Insights of Penam Laboratories.
Penam Laboratories Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 47.57% increase. The company also saw a substantial improvement in profitability, with a 36.58% increase in profit. The company's net worth Soared by an impressive increase of 12.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Penam Laboratories?
In 2023, Penam Laboratories had a promoter holding of 95.23% and a public holding of 4.77%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sampark Overseas Private LimitedActive 22 years 10 monthsRaj Ajmani and Ashish Ajmani are mutual person
- Continental Manufactures Private LimitedActive 43 years 3 months
Raj Ajmani, Surender Ajmani and 1 more are mutual person
- D Kumar Consulting Engineers Private LimitedActive 53 years 6 months
Raj Ajmani and Surender Ajmani are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 04 Sep 2013 | ₹16.00 Cr | Satisfied |
Statebank Of India Creation Date: 26 Jun 1998 | ₹21.84 Cr | Satisfied |
Ifci Creation Date: 26 Aug 1997 | ₹6.90 Cr | Satisfied |
How Many Employees Work at Penam Laboratories?
Penam Laboratories has a workforce of 192 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Penam Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Penam Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
